OREANDA-NEWS. According to the first interim data of the third phase of the trial of the Russian COVID-19 vaccine Sputnik V, the effectiveness of the drug has been successfully proven, the Gamaleya Research Institute of Epidemiology and Microbiology of the Ministry of Health and the Russian Direct Investment Fund reported.

The effectiveness of the vaccine was evaluated based on the results of surveys with the participation of more than 16 thousand volunteers, 21 days after receiving the first dose of the medication or placebo. Then they received a second dose, after which the effectiveness of the drug was measured.

“The statistical analysis included 20 confirmed cases of infection. According to the distribution of 20 confirmed cases (identified in the placebo group and in the group receiving the vaccine), it was determined that the effectiveness of Sputnik V is 92 %,” the statement says.